🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

15 recruiting trials

for Carcinoid

Genetics of Appendix Cancer Study NCT05734430n/a1 site📍 Nashville Andreana Holowatyj, PhD, MSCI · Tests: Genetic profiling, Retrospective tissue procurement Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors NCT05263050Phase 21 site📍 Philadelphia Fox Chase Cancer Center · Tests: Cabozantinib, Nivolumab Natural History of Familial Carcinoid Tumor NCT00646022n/a1 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… · Tests: [18F]-DOPA Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers NCT00900419n/a1 site📍 Aurora University of Colorado, Denver · Tests: immunohistochemistry staining method, laboratory biomarker analysis, sputum cytology, biopsy Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors NCT07357623Phase 24 sites📍 Hefei📍 Beijing📍 Zhengzhou Shanghai Chest Hospital · Tests: Surufatinib Combined With Standard chemotherapy, Surufatinib Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery. NCT04735198NA6 sites📍 Badalona📍 Barcelona📍 Barcelona Hospital Universitari de Bellvitge · Tests: Primary tumor surgery, Primary tumor surgery (bowel resection) combined with prophylactic cholecystectomy Life Following Excision of Neuroendocrine Tumors NCT06981455n/a1 site📍 Toronto Sunnybrook Health Sciences Centre Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. NCT07165132Phase 114 sites📍 Phoenix📍 Jacksonville📍 Iowa City RayzeBio, Inc. · Tests: RYZ401 DNA Analysis of Blood and Tissue From Patients With Lung Cancer NCT00471978n/a2 sites📍 Boston📍 Boston Massachusetts General Hospital Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors NCT06472388Phase 22 sites📍 São Paulo📍 São Paulo AC Camargo Cancer Center · Tests: Everolimus 5 MG Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET) NCT04086485Phase 1, Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Lu-177-DOTATATE, Olaparib, Ga dotatate scanning, FDG-PET scanning, Amino Acid infusion Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes NCT04907643NA1 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: PICO G2 4k At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer NCT05969860Phase 22 sites📍 Jacksonville📍 Grand Forks Mayo Clinic · Tests: Clinical Encounter, Home Health Encounter, Quality-of-Life Assessment, Questionnaire Administration Pharmaceutical Management in Targeted Radioligand Therapy NCT07389512n/a3 sites📍 Bron📍 Dijon📍 Lille Hospices Civils de Lyon ALG-LungCancerRegistry (SAFRO2202) NCT07161882n/a21 sites📍 Algiers📍 Algiers📍 Algiers Société Algérienne de Formation et de Recherche en Oncologie · Tests: Observational Data Collection
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy